Do new antiepileptic drugs justify their expense?
Chadwick
D
D
Department of Neurological Science, The Walton Center for Neurology and Neurosurgery, Liverpool University, England.
D000927:Anticonvulsants / Q000009:adverse effects / Q000191:economics / Q000494:pharmacology*; D003362:Cost-Benefit Analysis; D004345:Drug Industry / Q000191:economics; D015507:Drugs, Investigational / Q000009:adverse effects / Q000191:economics / Q000494:pharmacology*; D014943:Global Health; D006801:Humans
D000927:Anticonvulsants; D015507:Drugs, Investigational